Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease-Reference-Cited by-同舟云学术

Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease

Published:2016-01 Issue:1 Volume:36 Page:189-197
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:Arterioscler Thromb Vasc Biol.

Author:

Gurbel Paul A.¹,Bliden Kevin P.¹,Turner Susan E.¹,Tantry Udaya S.¹,Gesheff Martin G.¹,Barr Travis P.¹,Covic Lidija¹,Kuliopulos Athan¹

Affiliation:

1. From the Sinai Center for Thrombosis Research, Sinai Hospital of Baltimore, MD (P.A.G., K.P.B., U.S.T., M.G.G.); and the Center for Hemostasis and Thrombosis Research, MORI, Tufts Medical Center, Boston, MA (S.E.T., T.P.B., L.C., A.K.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets

2. Platelet Function Testing and Genotyping Improve Outcome in Patients Treated With Antithrombotic Agents

3. G-Protein–Coupled Receptors Signaling Pathways in New Antiplatelet Drug Development

4. Protease-Activated Receptors in Cardiovascular Diseases

5. Bivalirudin Is a Dual Inhibitor of Thrombin and Collagen-Dependent Platelet Activation in Patients Undergoing Percutaneous Coronary Intervention

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. P2Y12 Receptor Inhibitor for Antiaggregant Therapies: From Molecular Pathway to Clinical Application;International Journal of Molecular Sciences;2024-07-10

2. Thrombin receptor PAR1 silencing in endothelial colony–forming cells modifies stemness and vasculogenic properties;Journal of Thrombosis and Haemostasis;2023-12

3. Suppression of Heart Failure With PAR1 Pepducin Technology in a Pressure Overload Model in Mice;Circulation: Heart Failure;2023-07-21

4. Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs: Development, Strategies, and Progress;Biomedicines;2023-07-12

5. An update on novel therapies for treating patients with arterial thrombosis;Expert Review of Hematology;2023-06-26